IDEXX LABORATORIES INC IDXX 73
Health Care · NASDAQ · Data as of 2026-08-04
IDEXX LABORATORIES INC (IDXX) has delivered +10.5% annualized revenue growth, +18.7% earnings growth, and n/a dividend growth over 10 years of data. Ranked #201 of 1968 stocks overall and #21 of 260 in the Health Care sector by Steady Score.
About IDEXX LABORATORIES INC
Company Overview
IDEXX Laboratories develops diagnostic products and software for veterinary practices, livestock and water testing. Companion-animal clinics use its in-house analyzers, consumable tests, reference laboratories, imaging systems and practice-management software to diagnose and manage animal health. The company also supplies tests for milk safety and livestock disease and instruments that detect microbial contamination in drinking and recreational water.
Read more
Business Model & Revenue
IDEXX earns revenue from diagnostic instruments, recurring consumables, reference-lab services and software subscriptions. Placing an analyzer in a clinic can generate repeat purchases of compatible slides, kits and service throughout its use. Reference labs charge per test, while software and connectivity products use subscription arrangements. Veterinary visits, test utilization, installed instruments and clinician adoption drive growth, with direct sales and support reinforcing customer relationships.
Key Facts & Market Position
Companion Animal Group is the core business, linking point-of-care testing, outside laboratories and workflow software within veterinary practices. This integrated model serves both medical decisions and clinic operations. A large installed analyzer base supports consumable demand, while diagnostic accuracy, innovation, service reliability and veterinary staffing influence utilization and competitive position.